There are various pharmaceutical organizations, such as contract pharmaceutical development and manufacturing organizations (CDMOs) that have the capabilities to offer active pharmaceutical ingredient development or API development services.
The market size for high potency API contract manufacturing was estimated to be USD 6.74 billion in 2021, and it is anticipated to expand at a compound annual growth rate (CAGR) of 9.0% during the forecast period. Increasing high potency API (HPAPI) manufacturing technology advancements, along with the search for more potent medications to improve patient outcomes, have significantly increased the number of HPAPIs in development pipelines, speeding the industry’s growth. These are just a few of the factors promoting the industry’s growth.
The leading companies offering custom API development services are mentioned below.
Novartis International AG
Novartis International AG, headquartered in Switzerland, provides patented prescription medicines to patients. The company’s Sandoz segment offers active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas.
Ofichem – API Development Services
The Ofichem Group manufactures, develops and distributes active pharmaceutical ingredients (APIs) for both the veterinary and human market.
Pfizer CentreOne – API Contract Manufacturing Services
Pfizer CentreOne is a global contract development and manufacturing organization (CDMO) backed by Pfizer resources and a leading supplier of specialty APIs.
TAPI
TAPI (Teva Active Pharmaceutical Ingredients) is one of the leading manufacturers of APIs in the world at present with more than 75 years of experience and around USD 750 million in third party sales. The company presently holds the industry’s largest portfolio of more than 300 APIs.
Minakem – HPAPI & API development services
MINAKEM is a fully integrated development partner (CDMO) and commercial manufacturer of APIs, Highly Potent APIs for pharmaceutical companies.
Polpharma – Active Pharmaceutical Ingredient Development Services
Poland-based CDMO and manufacturer of active pharmaceutical ingredients (APIs). Highest quality of products and cost-competitive processes.
Solara Active Pharma Sciences – Custom API development services
Phyton Biotech LLC – Plant-based drug substance development services
Phyton Biotech is a pharmaceutical R&D/mfg company specializing in Plant Cell Fermentation (PCF) technology to create drugs that treat cancer & other diseases.
The API market is extremely crowded and cutthroat. Top suppliers in the sector include Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals. A number of businesses have participated in mergers and acquisitions over the past ten years to grow their market share. Consolidation is a major driving force behind mergers and acquisitions, which have various advantages including better access to acquiring raw materials, distribution, and R&D.